Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sven Perner

Showing results (131-140 of 296) with videos related to

Pageof 30
Sort By:
Urology|May 16, 2006
Prognostic factors in lymph node-positive prostate cancerMatthias D Hofer, Rainer Kuefer, Wei Huang, et al.
International Journal of Cancer|July 4, 2017
Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancerSabrina Schecher, Britta Walter, Michael Falkenstein, et al.
Urologic Oncology|March 2, 2020
Histomorphological analysis of false positive PI-RADS 4 and 5 lesionsMarie Christine Hupe, Anne Offermann, Lars Tharun, et al.
The American Journal of Pathology|July 13, 2014
KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomyJohannes Stein, Michael Majores, Magdalena Rohde, et al.
Head & Neck|August 6, 2013
Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancerAndreas Schröck, Friederike Göke, Patrick Wagner, et al.
Plos One|September 16, 2021
Cracking it - successful mRNA extraction for digital gene expression analysis from decalcified, formalin-fixed and paraffin-embedded bone tissueAlireza Saraji, Anne Offermann, Janine Stegmann-Frehse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2009
Aberrant cytoplasmic expression of p63 and prostate cancer mortalityPreet K Dhillon, Marc Barry, Meir J Stampfer, et al.
Urology|September 7, 2012
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancerPhilip Rosen, David Pfister, Denise Young, et al.
The American Journal of Pathology|March 21, 2015
Clinical and molecular implications of MED15 in head and neck squamous cell carcinomaDavid Adler, Anne Offermann, Rebecca Halbach, et al.
Frontiers in Oncology|November 15, 2021
Spatial Distribution of Immune Cells in Head and Neck Squamous Cell CarcinomasChristian Idel, Julika Ribbat-Idel, Luise Klapper, et al.
Pageof 30

Showing results (131-140 of 296) with videos related to

Sort By:
Pageof 30
Urology|May 16, 2006
Prognostic factors in lymph node-positive prostate cancerMatthias D Hofer, Rainer Kuefer, Wei Huang, et al.
International Journal of Cancer|July 4, 2017
Cyclin K dependent regulation of Aurora B affects apoptosis and proliferation by induction of mitotic catastrophe in prostate cancerSabrina Schecher, Britta Walter, Michael Falkenstein, et al.
Urologic Oncology|March 2, 2020
Histomorphological analysis of false positive PI-RADS 4 and 5 lesionsMarie Christine Hupe, Anne Offermann, Lars Tharun, et al.
The American Journal of Pathology|July 13, 2014
KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomyJohannes Stein, Michael Majores, Magdalena Rohde, et al.
Head & Neck|August 6, 2013
Fibroblast growth factor receptor-1 as a potential therapeutic target in sinonasal cancerAndreas Schröck, Friederike Göke, Patrick Wagner, et al.
Plos One|September 16, 2021
Cracking it - successful mRNA extraction for digital gene expression analysis from decalcified, formalin-fixed and paraffin-embedded bone tissueAlireza Saraji, Anne Offermann, Janine Stegmann-Frehse, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 22, 2009
Aberrant cytoplasmic expression of p63 and prostate cancer mortalityPreet K Dhillon, Marc Barry, Meir J Stampfer, et al.
Urology|September 7, 2012
Differences in frequency of ERG oncoprotein expression between index tumors of Caucasian and African American patients with prostate cancerPhilip Rosen, David Pfister, Denise Young, et al.
The American Journal of Pathology|March 21, 2015
Clinical and molecular implications of MED15 in head and neck squamous cell carcinomaDavid Adler, Anne Offermann, Rebecca Halbach, et al.
Frontiers in Oncology|November 15, 2021
Spatial Distribution of Immune Cells in Head and Neck Squamous Cell CarcinomasChristian Idel, Julika Ribbat-Idel, Luise Klapper, et al.
Pageof 30